Performance of two questionnaires to measure treatment adherence in patients with Type-2 Diabetes

被引:20
|
作者
Prado-Aguilar, Carlos A. [1 ,4 ]
Martinez, Yolanda V. [1 ]
Segovia-Bernal, Yolanda [2 ]
Reyes-Martinez, Rosendo [3 ]
Arias-Ulloa, Raul [4 ]
机构
[1] Inst Mexicano Seguro Social, Unidad Invest Epidemiol & Serv Salud, Hosp Gen Zona 1, Aguascalientes, Ags, Mexico
[2] Inst Mexicano Seguro Social, Unidad Med Ambulatoria, Aguascalientes, Ags, Mexico
[3] Inst Mexicano Seguro Social, Unidad Med Familiar, Aguascalientes, Ags, Mexico
[4] Univ Autonoma Aguascalientes, Depto Salud Publ, Aguascalientes, Ags, Mexico
来源
BMC PUBLIC HEALTH | 2009年 / 9卷
关键词
MEDICATION ADHERENCE; THERAPY;
D O I
10.1186/1471-2458-9-38
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Most valid methods to measure treatment adherence require time and resources, and they are not easily applied in highly demanding Primary Health Care Clinics (PHCC). The objective of this study was to determine sensitivity, specificity, predictive values, likelihood ratios, and post-test probabilities of two novel questionnaires as proxy measurements of treatment adherence in Type-2 diabetic patients. Methods: Two questionnaires were developed by a group of experts to identify the patient's medical prescription knowledge (knowledge) and their attitudes toward treatment adherence (attitudes) as proxy measurements of adherence. The questionnaires were completed by patients receiving care in PHCC pertaining to the Mexican Institute of Social Security in Aguascalientes (Mexico). Pill count was used as gold standard. Participants were selected randomly, and their oral hypoglycemic prescriptions were studied. The main outcome measures for each questionnaire were sensitivity, specificity, predictive values, likelihood ratios, and post-test probabilities, all as an independent questionnaire test and in a serial analysis. Results: Adherence prevalence was 27.0% using pill count. Knowledge questionnaire showed the highest sensitivity (68.1%) and negative predictive value (82.2%), the lowest negative likelihood ratio (0.58) and post-test probability for a negative result (0.16). Serial analysis showed the highest specificity (77.4%) and positive predictive value (40.1%) as well as the highest positive likelihood ratio (1.8) and post-test probability for a positive result (0.39). Conclusion: Medical Prescription Knowledge questionnaire showed the best performance as proxy measurement to identify non-adherence in type 2 diabetic patients regarding negative predictive value, negative likelihood ratio, and post-test probability for a negative result. However, Medical Prescription Knowledge questionnaire performance may change in contexts with higher adherence prevalence. Therefore, more research is needed before using this method in other contexts.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Race and medication adherence in Medicaid enrollees with type-2 diabetes
    Shenolikar, Rahul A.
    Balkrishnan, Rajesh
    Camacho, Fabian T.
    Whitmire, J. Timothy
    Anderson, Roger T.
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2006, 98 (07) : 1071 - 1077
  • [22] Asymptomatic bacteriuria in patients with Type-2 Diabetes mellitus Asymptomatic bacteriuria in patients with Type-2 Diabetes mellitus
    Chandra, A.
    Singh, S. P.
    Kumar, V.
    Ahmed, K. A.
    Kumar, P.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 186
  • [23] Adherence to medicamentous therapy of type 2 diabetes mellitus: results of patient questionnaires
    Surkova, E., V
    Melnikova, O. G.
    DIABETES MELLITUS, 2009, 12 (01): : 48 - 50
  • [24] Treatment Persistence and Adherence in Patients with Type 2 Diabetes Mellitus in Japan Based on Two Administrative Databases
    Nishimura, Rimei
    Kato, Haruka
    Kisanuki, Koichi
    Kikuchi, Takashi
    Mineyama, Tomoka
    Guelfucci, Florent
    Hiroi, Shinzo
    DIABETES, 2017, 66 : A452 - A452
  • [25] Psychosocial Determinants of Treatment Adherence in Patients with Type 2 Diabetes - A Review
    Swiatoniowska-Lonc, Natalia
    Tanski, Wojciech
    Polanski, Jacek
    Jankowska-Polanska, Beata
    Mazur, Grzegorz
    DIABETES METABOLIC SYNDROME AND OBESITY, 2021, 14 : 2701 - 2715
  • [26] Coping strategies and adherence to treatment in patients with type 2 diabetes mellitus
    Eugenia Garay-Sevilla, Ma
    Santiago Porras, Jose
    Manuel Malacara, Juan
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2011, 63 (02): : 155 - 161
  • [27] Medication Adherence Affects Treatment Modifications in Patients With Type 2 Diabetes
    Voorham, Jaco
    Haaijer-Ruskamp, Flora M.
    Wolffenbuttel, Bruce H. R.
    Stolk, Ronald P.
    Denig, Petra
    CLINICAL THERAPEUTICS, 2011, 33 (01) : 121 - 134
  • [28] Medical treatment of retinopathy of type-2 diabetes
    Cunha-Vaz, JG
    OPHTHALMOLOGICA, 2004, 218 (05) : 291 - 296
  • [29] COMPOSITE ENDPOINTS IN TREATMENT OF TYPE-2 DIABETES
    Einarson, T. R.
    Hemels, M.
    VALUE IN HEALTH, 2013, 16 (03) : A13 - A14
  • [30] FUTURE TREATMENT STRATEGIES FOR TYPE-2 DIABETES
    LEBOVITZ, HE
    DIABETES 1988, 1989, 800 : 365 - 368